Alejandra Raimondi
- Molecular Biology top 5%
- Hematology top 5%
- Oncology
- Epidemiology
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- Robert A. CopelandChristine R. KlausMikel P. MoyerMargaret Porter ScottRoy M. PollockRichard ChesworthVictoria M. RichonChristina J. Allain
- Topics
- Epigenetics and DNA Methylation (16 papers)Cancer-related gene regulation (16 papers)Acute Myeloid Leukemia Research (6 papers)
- Partner nations
- United StatesSwedenArgentina
In The Last Decade
Alejandra Raimondi
23 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Molecular Biology 1.5k
- Hematology 247
- Oncology 208
- Epidemiology 196
- Public Health, Environmental and Occupational Health 148
Countries citing papers authored by Alejandra Raimondi
This map shows the geographic impact of Alejandra Raimondi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandra Raimondi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandra Raimondi more than expected).
Fields of papers citing papers by Alejandra Raimondi
This network shows the impact of papers produced by Alejandra Raimondi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandra Raimondi. The network helps show where Alejandra Raimondi may publish in the future.
Co-authorship network of co-authors of Alejandra Raimondi
This figure shows the co-authorship network connecting the top 25 collaborators of Alejandra Raimondi. A scholar is included among the top collaborators of Alejandra Raimondi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandra Raimondi. Alejandra Raimondi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 52 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 94 | |
| 9 | 0 | |
| 10 | 96 | |
| 11 | 55 | |
| 12 | 64 | |
| 13 | Potent inhibition of DOT1L as treatment of MLL-fusion leukemiabreakdown → | 546 |
| 14 | 5 | |
| 15 | Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2breakdown → | 581 |
| 16 | 3 | |
| 17 | 140 | |
| 18 | 39 | |
| 19 | 4 | |
| 20 | 131 |
About Alejandra Raimondi
Alejandra Raimondi is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine, having authored 27 papers that have together received 1.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (16 papers), Cancer-related gene regulation (16 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Hematology (247 citations), Molecular Biology (1.5k citations) and Cancer Research (125 citations). Alejandra Raimondi has collaborated with scholars based in United States, Sweden and Argentina. Frequent co-authors include Robert A. Copeland, Christine R. Klaus, Mikel P. Moyer, Margaret Porter Scott, Roy M. Pollock, Richard Chesworth, Victoria M. Richon, Christina J. Allain, Sarah K. Knutson and Heike Keilhack. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.